Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01622153 · ClinicalTrials.gov registry record · NA
Electrical and Formocresol Pulpotomy in Primary Molars
A NA study, sponsored by University Hospitals Cleveland Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT01622153 is a NA study that was terminated before completion, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 120 participants.
The verdict
NCT01622153, a NA study, was terminated before completion, sponsored by University Hospitals Cleveland Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
1. The investigator hypothesize that the Laser pulpotomy will provide adequate and comparable success clinically in primary molars. 2. The investigators hypothesize that the Laser pulpotomy will provide adequate and comparable success radiographically in primary molars.
Interventions
- PROCEDURE Formocresol application after pulpotomy preparation
- PROCEDURE GENTLEray 980 Soft Tissue diode laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2011-06 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01622153
The ClinicalTrials.gov registry entry for NCT01622153 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Formocresol application after pulpotomy preparation is the first listed.
NCT01622153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01622153 about?
NCT01622153 is a clinical study titled "Electrical and Formocresol Pulpotomy in Primary Molars". 1. The investigator hypothesize that the Laser pulpotomy will provide adequate and comparable success clinically in primary molars. 2. The investigators hypothesize that the Laser pulpotomy will provide adequate and comparable success radiographically in primary molars.
What is the current status of trial NCT01622153?
This trial is currently terminated. It is a NA study. The enrollment target is 120 participants. The study started on 2011-06. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01622153?
The interventions under investigation include: Formocresol application after pulpotomy preparation (PROCEDURE), GENTLEray 980 Soft Tissue diode laser (PROCEDURE).
Who is sponsoring clinical trial NCT01622153?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.